NO20044554L - Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener - Google Patents

Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener

Info

Publication number
NO20044554L
NO20044554L NO20044554A NO20044554A NO20044554L NO 20044554 L NO20044554 L NO 20044554L NO 20044554 A NO20044554 A NO 20044554A NO 20044554 A NO20044554 A NO 20044554A NO 20044554 L NO20044554 L NO 20044554L
Authority
NO
Norway
Prior art keywords
melagatran
combination product
oxabispidens
antiarrhythmic
compound
Prior art date
Application number
NO20044554A
Other languages
English (en)
Inventor
Elisabeth Svernhage
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20044554L publication Critical patent/NO20044554L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er tilveiebrakt et kombinasjonsprodukt omfattende: melagatran eller et farmasøytisk akseptabelt derivat derav; og (1) en forbindelse defmert i krav 1 ifølge WO 01/28992, eller (2) en forbindelse ifølge krav 34 i WO 01/28992, eller (3) forbindelse A eller B eller C eller D (eller farmasøytisk akseptable salter derav) for anvendelse ved behandling av arytmi eller en koagulasjonskonfrollert komplikasjon ved denne.
NO20044554A 2002-05-06 2004-10-22 Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener NO20044554L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201373A SE0201373D0 (sv) 2002-05-06 2002-05-06 Combination therapy
PCT/SE2003/000720 WO2003092721A1 (en) 2002-05-06 2003-05-05 A combination product comprising melagatran and an anti-arrhythmic oxabispidenes

Publications (1)

Publication Number Publication Date
NO20044554L true NO20044554L (no) 2004-11-16

Family

ID=20287788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044554A NO20044554L (no) 2002-05-06 2004-10-22 Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener

Country Status (19)

Country Link
US (1) US20060074080A1 (no)
EP (1) EP1503782A1 (no)
JP (1) JP2005531546A (no)
KR (1) KR20050007470A (no)
CN (1) CN1652811A (no)
AR (1) AR039572A1 (no)
AU (1) AU2003224590A1 (no)
BR (1) BR0309354A (no)
CA (1) CA2483001A1 (no)
IL (1) IL164869A0 (no)
IS (1) IS7561A (no)
MX (1) MXPA04010716A (no)
NO (1) NO20044554L (no)
PL (1) PL372368A1 (no)
RU (1) RU2004129730A (no)
SE (1) SE0201373D0 (no)
TW (1) TW200403071A (no)
WO (1) WO2003092721A1 (no)
ZA (1) ZA200408615B (no)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
US6462021B1 (en) * 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor

Also Published As

Publication number Publication date
JP2005531546A (ja) 2005-10-20
ZA200408615B (en) 2006-04-26
BR0309354A (pt) 2005-02-15
PL372368A1 (en) 2005-07-25
CA2483001A1 (en) 2003-11-13
SE0201373D0 (sv) 2002-05-06
AU2003224590A1 (en) 2003-11-17
US20060074080A1 (en) 2006-04-06
KR20050007470A (ko) 2005-01-18
MXPA04010716A (es) 2005-03-07
EP1503782A1 (en) 2005-02-09
CN1652811A (zh) 2005-08-10
WO2003092721A1 (en) 2003-11-13
TW200403071A (en) 2004-03-01
AR039572A1 (es) 2005-02-23
IS7561A (is) 2004-11-29
IL164869A0 (en) 2005-12-18
RU2004129730A (ru) 2005-07-10

Similar Documents

Publication Publication Date Title
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
TW200505881A (en) Tri(cyclo) substituted amide compounds
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
GB9822450D0 (en) Medicaments
NO20065904L (no) Terapeutiske forbindelser
WO2003013484A3 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
GEP20043324B (en) Purine Derivatives
NO20054852L (no) GFAT inhibitorer
NO20050662L (no) COX-2 inhiberende pyridinderivater
MX9402938A (es) Composicion terapeutica que comprende nicotinamida-adenina-dinucleotido ynicotinamida-adenina-fosfato-dinucleotido, estable ingerible y absorbible.
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20052182L (no) Nye forbindelser
NO20060020L (no) 3-fluorpiperidiner som NMDA/NR2B-antagonister
DE60322417D1 (en) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1,8-naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
GB0222514D0 (en) Organic compounds
DE602004011966D1 (en) Heterocyclylverbindungen
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
MY140164A (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
NO20044673L (no) Farmasoytisk kombinasjon
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
NO20044554L (no) Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener
MY138698A (en) Method for synthesis of (2s)-indoline-2-carboxylic acid, and use in the synthesis of perindopril

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application